Sphingosine-1-phosphate modulates PAR1-mediated human platelet activation in a concentration-dependent biphasic...

Area of Science:

• Biochemistry
• Immunology
• Physiology

Background:

• Sphingosine 1-phosphate (S1P) is a lipid mediator implicated in various diseases, including obesity and diabetes.
• S1P's role in regulating human platelet function and the specific receptors involved remain controversial.

Purpose of the Study:

• To elucidate the precise role of S1P in modulating human platelet aggregation.
• To identify the specific sphingosine 1-phosphate receptors (S1PRs) responsible for S1P-mediated platelet priming.

Main Methods:

• Human platelets were stimulated with protease-activated receptor 1 (PAR-1) activating peptide.
• Platelet responses were assessed in the presence of S1P, S1PR agonists/antagonists, and sphingosine kinase inhibitors.
• The effects of specific S1PR subtype activation on platelet function were evaluated.

Main Results:

• S1P exhibited a biphasic effect on platelet function: low concentrations enhanced PAR1-mediated responses, while high concentrations inhibited them.
• S1PR1 activation promoted platelet priming, whereas S1PR4 and S1PR5 activation inhibited PAR-1 mediated platelet function.
• Dual or Sphingosine Kinase 2 (SphK2) inhibition significantly reduced platelet function, suggesting SphK2-mediated S1P generation is crucial.

Conclusions:

• S1P plays a concentration-dependent role in priming human platelet function.
• S1P exerts its effects through distinct S1PRs: S1PR1 for enhancement and S1PR4/5 for inhibition.
• SphK2-dependent S1P generation is critical for these modulatory effects on platelets.